A review of therapeutic effects of curcumin

Current Pharmaceutical Design

Volumn 19, Issue 11, 2013, Pages 2032-2046

  Noorafshan, Ali ^a   Ashkani Esfahani, Soheil ^b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Curcumin; Review; Therapeutic effects

Indexed keywords

BISDEMETHYOXYCURCUMIN; CISPLATIN; CURCUMIN; DEMETHOXYCURCUMIN; DOXORUBICIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANTIANGIOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BLADDER CANCER; BRAIN DISEASE; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN TUMOR; BREAST CANCER; CANCER INHIBITION; CARDIOMYOPATHY; CELL GROWTH; CHRONIC INFLAMMATION; CLINICAL TRIAL; COLON CANCER; CROHN DISEASE; DEGENERATIVE DISEASE; DEPRESSION; DIABETES MELLITUS; DIABETIC CARDIOMYOPATHY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DIGESTIVE SYSTEM CANCER; DIGESTIVE SYSTEM ULCER; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DOSE INCREASE; DRUG EFFECT; DRUG ELIMINATION; DRUG EXCRETION; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENTIATION; DRUG SAFETY; DRUG STRUCTURE; DYSMENORRHEA; ENCEPHALITIS; ENDOCRINE TUMOR; ENTERITIS; FIBROSARCOMA; FLUID PERCUSSION INJURY; GENITAL TRACT CANCER; HEAD AND NECK TUMOR; HEART FAILURE; HEART INFARCTION; HEART INJURY; HEART VENTRICLE HYPERTROPHY; HEPATIC ENCEPHALOPATHY; HEPATITIS; HEPATOBILIARY SYSTEM CANCER; HUMAN; HYPOTHYROIDISM; INFLAMMATION; INSULIN RESISTANCE; IRON OVERLOAD; JAUNDICE; KIDNEY CANCER; KIDNEY CARCINOMA; KIDNEY FIBROSIS; KIDNEY INJURY; KIDNEY ISCHEMIA; LIVER CANCER; LIVER CIRRHOSIS; LIVER INJURY; LUNG CANCER; LUNG METASTASIS; MIDDLE CEREBRAL ARTERY OCCLUSION; MULTIPLE SCLEROSIS; NEPHRITIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OSTEOARTHRITIS; OSTEOPOROSIS; OSTEOSARCOMA; OVARY CANCER; OXIDATIVE KIDNEY INJURY; PANCREAS CANCER; PANCREAS TUMOR; PANCREATITIS; PARKINSON DISEASE; PNEUMONIA; PRIORITY JOURNAL; PROSTATE CANCER; PSORIASIS; SKIN INJURY; TRAUMATIC BRAIN INJURY; ULCERATIVE COLITIS; UTERINE CERVIX CANCER; UTERUS CANCER; WOUND;

EID: 84875399748     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161213805289273     Document Type: Article

References (230)

1. Milobedzka J, V. Kostanecki S, Lampe V. Curcumin. Ber Dtsch Chem Ges 1910; 43: 2163-70.
2. Lampe V, Milobedzka J. Curcumin. Ber Dtsch Chem Ges 1913; 46: 2235-40.
3. Ammon H, Wahl MA. Pharmacology of Curcuma longa. Planta Med 1991; 57: 1-7.
4. Tilak J, Banerjee M, Mohan H, Devasagayam TPA. Antioxidant availability of turmeric in relation to its medicinal and culinary uses. Phytotherapy Research 2004; 18(10): 798-804.
5. Aggarwal BB, Sundaram C, Malani N, Ichikawa H. Curcumin: The Indian solid gold. Adv Exp Med Biol 2007; 595: 1-75.
6. Thakur R, Puri HS, Husain A. Major medicinal plants of India. Medicinal plants; Materia medica, Vegetable; Traditional medicine; India. Lucknow: Central Institute of Medicinal and Aromatic Plants 1989. p. 585.
7. Pandeya NK. Old Wives' Tales: Modern Miracles-Turmeric as Traditional Medicine in India. Trees for Life J 2005; 1: 3.
8. Jaruga E, Salvioli S, Dobrucki J, et al. Apoptosis-like, reversible changes in plasmamembrane asymmetry and permeability, and transient modifications in mitochondrial membrane potential induced by curcumin in rat thymocytes. FEBS Lett 1998; 433(3): 287-93.
9. Jarugaa E, Sokala A, Chrulb S, Bartosza G. Apoptosis-independent alterations in membrane dynamics induced by curcumin. Exp Cell Res 1998; 245(2): 303-12.
10. Ireson C, Orr S, Jones DJ, et al. Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production. Cancer Res 2001; 61: 1058-64.
11. Ireson CR, Jones DJ, Orr S, et al. Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiol Biomarkers Prev 2002; 11: 105-11.
12. Ramsewak RS, DeWitt DL, Nair MG. Cytotoxicity, antioxidant and anti-inflammatory activities of curcumins I-III from Curcuma longa. Phytomedicine 2000; 7(4): 303-8.
13. Sreejayan MNA. Curcuminoids as potent inhibitors of lipid peroxidation. J Pharm Pharmacol 1994; 46(12): 1013-6.
14. Ruby A, Kuttan G, Babu KD, Rajasekharan KN, Kuttan R. Antitumour and antioxidant activity of natural curcuminoids. Cancer Lett 1995; 94(1): 79-83.
15. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm 2007; 4(6): 807-18.
16. Payton F, Sandusky P, Alworth WL. NMR study of the solution structure of curcumin. J Nat Prod 2007; 70(2): 143-6.
17. Weber WM, Hunsaker LA, Roybal CN, et al. Activation of NFκB is inhibited by curcumin and related enones. Bioorg Med Chem 2006; 14(7): 2450-61.
18. Ishida J, Ohtsu H, Tachibana Y, et al. Antitumor Agents. Part 214: + Synthesis and Evaluation of Curcumin Analogues as Cytotoxic Agents. Bioorg Med Chem 2002; 10(11): 3481-7.
19. Ohori H, Yamakoshi H, Tomizawa M, et al. Synthesis and biological analysis of new curcumin analogues bearing an enhanced potential for the medicinal treatment of cancer. Mol Cancer Ther 2006; 5(10): 2563-71.
20. Selvam C, Jachak SM, Thilagavathi R, Chakraborti AK. Design, synthesis, biological evaluation and molecular docking of curcumin analogues as antioxidant, cyclooxygenase inhibitory and antiinflammatory agents. Bioorg Med Chem Lett 2005; 15(7): 1793-7.
21. Sun A, Shoji M, Lu YJ, Liotta DC, Snyder JP. Synthesis of EF24- tripeptide chloromethyl ketone: a novel curcumin-related anticancer drug delivery system. J Med Chem 2006; 49(11): 3153-8.
22. Arezzini B, Ferrali M, Ferrari E, Grandi R, Monti S, Saladini M. Glycosyl-curcuminoids as potential new chelating agents in iron overload chelation therapy. Eur J Inorg Chem 2004; 2004(3): 646-52.
23. Bharat BA, Harikumar KB. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases Int J Biochem Cell Biol 2009; 41: 40-59.
24. Li L, Braiteh FS, Kurzrock R. Liposomeencapsulated curcumin: In vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer Epidemiol Biomarkers Prev 2005; 104(6): 1322-31.
25. Maiti K, Mukherjee K, Gantait A, Saha BP, Mukherjee PK. Curcumin-phospholipid complex: Preparation, therapeutic evaluation and pharmacokinetic study in rats. Int J Pharm 2007; 330(1-2): 155-63.
26. Lin L, Shi Q, Nyarko AK, et al. Antitumor agents. 250. Design and synthesis of new curcumin analogues as potential anti-prostate cancer agents. J Med Chem 2006; 49(13): 3963-72.
27. Ohtsu H, Xiao Z, Ishida J, et al. Antitumor agents. 217. Curcumin analogues as novel androgen receptor antagonists with potential as anti-prostate cancer agents. J Med Chem 2002; 45(23): 5037-42.
28. Adams BK, Ferstl EM, Davis MC, et al. Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and antiangiogenesis agents. Bioorg Med Chem 2004; 12(14): 3871-83.
29. Nakano K, Nakayachi T, Yasumoto E, et al. Induction of apoptosis by beta-diketones in human tumor cells. Anticancer Res 2004; 24: 711-7.
30. Benassi R, Ferrari E, Grandi R, Lazzari S, Saladini M. Synthesis and characterization of new beta-diketo derivatives with iron chelating ability. J Inorg Biochem 2007; 101(2): 203-13.
31. Woo HB, Shin WS, Lee S, Ahn CM. Synthesis of novel curcumin mimics with asymmetrical units and their anti-angiogenic activity. Bioorg Med Chem Lett 2005; 15(16): 3782-6.
32. Shankar T, Shantha NV, Ramesh HP, Murthy IA, Murthy VS. Toxicity studies on turmeric (Curcuma longa): Acute toxicity studies in rats, guinea pigs and monkeys. Indian J Exp Biol 1980; 18(1): 73-5.
33. Soni K, Kuttan R. Effect of oral curcumin administration on serum peroxides and cholesterol levels in human volunteers. Indian J Physiol Pharmacol 1992; 36(4): 273-5.
34. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm 2007; 4: 807-18.
35. Sharma RA, Steward WP, Gescher AJ. Pharmacokinetics and pharmacodynamics of curcumin. Adv Exp Med Biol 2007; 595: 453-70.
36. Cheng AL, Hsu CH, Lin JK, et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 2001; 21(4B): 2895-900.
37. Lao CD, M.T.T. R, Normolle D, et al. Dose escalation of a curcuminoid formulation. BMC Complement Altern Med 2006; 6: 10.
38. Sharma RA, Euden SA, Platton SL, et al. Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res 2004; 10(20): 6847-54.
39. Yang KY, Lin LC, Tseng TY, Wang SC, Tsai TH. Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS/MS. Journal of Chromatography B 2007; 853(1-2): 183-9.
40. Wahlstrom B, Blennow G. A study on the fate of curcumin in the rat. Acta Pharmacol Toxicol (Copenh) 1978; 43(2): 86-92.
41. Lopez-Lazaro M. Anticancer and carcinogenic properties of curcumin: considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent. Mol Nutr Food Res 2008; 52(S1): S103-S27.
42. NTP. NTP Toxicology and Carcinogenesis Studies of Turmeric Oleoresin (CAS No. 8024-37-1) (Major Component 79-85% Curcumin, CAS No. 458-37-7) in F344/N Rats and B6C3F1 Mice (Feed Studies). Natl Toxicol Program Tech Rep Ser 1993; 427: 1-275.
43. Shishodia S, Sethi G, Aggarwal BB. Curcumin: Getting back to the roots. Ann N Y Acad Sci 2005; 1056: 206-17.
44. Amit S, Ben-Neriah Y. NF-kappaB activation in cancer: A challenge for ubiquitination- and proteasomebased therapeutic approach. Semin Cancer Biol 2003; 13(1): 15-28.
45. Hatcher H, Planalp R, Cho J, Torti FM, Torti SV. Curcumin: From ancient medicine to current clinical trials. Cell Mol Life Sci 2008; 65(11): 1631-52.
46. Thangapazham R, Sharma A, Maheshwari RK. Multiple molecular targets in cancer chemoprevention by curcumin. AAPS J 2006; 8(3): E443-9.
47. Mann J, DuBois RN. Cyclooxygenase-2 and gastrointestinal cancer. Cancer J 2004; 10(3): 145-52.
48. Prescott S. Is cyclooxygenase-2 the alpha and the omega in cancer? J Clin Invest 2000; 105(11): 1511-3.
49. Gao X, Kuo J, Jiang H, et al. Immunomodulatory activity of curcumin: Suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production in vitro. Biochem Pharmacol 2004; 68(1): 51-61.
50. Surh YJ. Anti-tumor promoting potential of selected spice ingredients with antioxidative and anti-inflammatory activities: a short review. Food Chem Toxicol 2002; 40(8): 1091-7.
51. Hanai H, Sugimoto K. Curcumin has Bright Prospects for the Treatment of Inflammatory Bowel Disease. Curr Pharm Des 2009; 15(18): 2087-94(8).8
52. Chan MM-Y, Huang H-I, Fenton MR, Fong D. In vivo Inhibition of Nitric Oxide Synthase Gene Expression by Curcumin, a Cancer Preventive Natural Product with Anti-inflammatory Properties. Biochemical Pharmacol 1998; 55(12): 1955-62.
53. Ebrahimi S, Esfahani SA, Kohkiloezadeh M, et al. A model of cerebral ischemia induction in neonatal rabbits. Journal of Applied Animal Research 2012 40(1): 37-42.
54. Antunes LMG, Araujo MCP, da Luz Dias F, Takahashi CS. Effects of H2O2, Fe2+ and Fe3+ on curcumin-induced chromosomal aberrations in CHO cells. Genet Mol Biol 2005; 28(1): 161-4.
55. Patro BS, Rele S, Chintalwar GJ, Chattopadhyay S, Adhikari S, Mukherjee T. Protective activities of some phenolic 1,3-diketones against lipid peroxidation: Possible involvement of the 1,3-diketone moiety. ChemBio-Chem 2002; 3(4): 364-70.
56. Jovanovic S, Boone CW, Steenken S, Trinoga M, Kaskey RB. How curcumin works preferentially with water soluble antioxidants. J Am Chem Soc 2001; 123(13): 3064-8.
57. Vajragupta O, Boonchoong P, Berliner LJ. Manganese complexes of curcumin analogues: Evaluation of hydroxyl radical scavenging ability, superoxide dismutase activity and stability towards hydrolysis. Free Radic Res 2004; 38(3): 303-14.
58. Barik A, Mishra B, Kunwar A, et al. Comparative study of copper(II)-curcumin complexes as superoxide dismutase mimics and free radical scavengers. Eur J Med Chem 2007; 42(4): 431-9.
59. Sreejayan RM. Nitric oxide scavenging by curcuminoids. J Pharm Pharmacol 1997; 49(1): 105-7.
60. Joe B, Lokesh BR. Role of capsaicin, curcumin and dietary n-3 fatty acids in lowering the generation of reactive oxygen species in rat peritoneal macrophages. Biochim Biophys Acta 1994; 1224(2): 255-63.
61. Lin J, Shih CA. Inhibitory effect of curcumin on xanthine dehydrogenase/oxidase induced by phorbol-12-myristate-13- acetate in NIH3T3 cells. Carcinogenesis 1994; 15(8): 1717-21.
62. Jefremov V, Zilmer M, Zilmer K, Bogdanovic N, Karelson E. Antioxidative effects of plant polyphenols: From protection of G protein signaling to prevention of age-related pathologies. Ann NY Acad Sci 2007; 1095: 449-57.
63. Bemis DL, Katz AE, Buttyan R. Clinical trials of natural products as chemopreventive agents for prostate cancer. Expert Opin Investig Drugs 2006; 15(10): 1191-200.
64. Bengmark S. Curcumin, an atoxic antioxidant and natural NFkappaB, cyclooxygenase-2, lipooxygenase, and inducible nitric oxide synthase inhibitor: a shield against acute and chronic diseases. JPEN J Parenter Enteral Nutr 2006; 30(1): 45-51.
65. Bengmark S, Mesa MD, Gil A. Plant-derived health: the effects of turmeric and curcuminoids. Nutr Hosp 2009; 24(3): 273-81.
66. Kunnumakkara AB, Anand P, Aggarwal BB. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett 2008; 269(2): 199-225.
67. Shanmugam MK, Kannaiyan R, Sethi G. Targeting cell signaling and apoptotic pathways by dietary agents: role in the prevention and treatment of cancer. Nutr Cancer 2011; 63(2): 161-73.
68. Thomasset SC, Berry DP, Garcea G, Marczylo T, Steward WP, Gescher AJ. Dietary polyphenolic phytochemicals-promising cancer chemopreventive agents in humans? A review of their clinical properties. Int J Cancer 2007; 120(3): 451-8.
69. Aggarwal BB, Sethi G, Ahn KS, et al. Targeting signal-transducerand- activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution. Ann N Y Acad Sci 2006; 1091: 151-69.
70. Kakarala M, Wicha MS. Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy. J Clin Oncol 2008; 26(17): 2813-20.
71. Kakarala M, Brenner DE, Korkaya H, et al. Targeting breast stem cells with the cancer preventive compounds curcumin and piperine. Breast Cancer Res Treat 2010; 122(3): 777-85.
72. Sandur SK, Ichikawa H, Pandey MK, et al. Role of pro-oxidants and antioxidants in the anti-inflammatory and apoptotic effects of curcumin (diferuloylmethane). Free Radic Biol Med 2007; 43(4): 568-80.
73. Yamaguchi H, Wang HG. The protein kinase PKB/Akt regulates cell survival and apoptosis by inhibiting Bax conformational change. Oncogene 2001; 20(53): 7779-86.
74. Jee S, Shen SC, Tseng CR, Chiu HC, Kuo ML. Curcumin induces a p53-dependent apoptosis in human basal cell carcinoma cells. J Invest Dermatol 1998; 111(4): 656-61.
75. Jiang M, Yang-Yen HF, Lin JK, Yen JJ. Differential regulation of p53, c-Myc, Bcl-2 and Bax protein expression during apoptosis induced by widely divergent stimuli in human hepatoblastoma cells. Oncogene 1996; 13(3): 609-16.
76. Choudhuri T, Pal S, Agwarwal ML, Das T, Sa G. Curcumin induces apoptosis in human breast cancer cells through p53- dependent Bax induction. FEBS Lett 2002; 512(1-3): 334-40.
77. Choudhuri T, Pal S, Das T, Sa G. Curcumin selectively induces apoptosis in deregulated cyclin D1-expressed cells at G2 phase of cell cycle in a p53-dependent manner. J Biol Chem 2005; 280: 20059-68.
78. Chen Y, Kuo TC, Lin-Shiau SY, Lin JK. Induction of HSP70 gene expression by modulation of Ca(12) ion and cellular p53 protein by curcumin in colorectal carcinoma cells. Mol Carcinogenesis 1996; 17: 224-34.
79. Bush J, Cheung K-JJ, Li G. Curcumin induces apoptosis in human melanoma cells through a Fas receptor/ caspase-8 pathway independent of p53. Exp Cell Res 2001; 271(2): 305-14.
80. Arbiser J, Klauber N, Rohan R, et al. Curcumin is an in vivo inhibitor of angiogenesis. Mol Med 1998; 4(6): 376-83.
81. Mohan R, Sivak J, Ashton P, et al. Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2, including expression of matrix metalloproteinase gelatinase B. J Biol Chem 2000; 275: 10405-12.
82. Gururaj A, Belakavadi M, Venkatesh DA, Marme D, Salimath BP. Molecular mechanisms of antiangiogenic effect of curcumin. Biochem Biophys Res Commun 2002; 297(4): 934-42.
83. Bhandarkar SS, Arbiser JL. Curcumin as an inhibitor of angiogenesis. Adv ExpMed Biol 2007; 595: 185-95.
84. Aggarwal BB, Sung B. Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends in Pharmacological Sciences 2008; 30(2): 85-94.
85. Purkayastha S, Berliner A, Fernando SS, et al. Curcumin blocks brain tumor formation. Brain Research 2009; 1266: 130-8.
86. Jing Lim K, Bisht S, Bar E, Maitra A, Eberhart C. A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors. Cancer Biol Ther 2011; 11(5): 464-73.
87. Kundu P, Mohanty C, Sahoo S. Antiglioma activity of curcuminloaded lipid nanoparticles and its enhanced bioavailability in brain tissue for effective glioblastoma therapy. Acta Biomaterialia 2012; 8(7): 2670-87.
88. Hsieh M-Y, Ponsford J, Wong D, McKay A. Exploring variables associated with change in cognitive behaviour therapy (CBT) for anxiety following traumatic brain injury. Disability and Rehabilitation 2012; 34(5): 408-15.
89. Sharma S, Zhuang Y, Ying Z, Wu A, Gomez-Pinilla F. Dietary curcumin supplementation counteracts reduction in levels of molecules involved in energy homeostasis after brain trauma. Neuroscience 2009; 161(4): 1037-44.
90. Kakkar V, Kau I. Evaluating potential of curcumin loaded solid lipid nanoparticles in aluminium induced behavioural, biochemical and histopathological alterations in mice brain. Food Chemical Toxicol 2011; 49(11): 2906-13.
91. Tian M, Wang L, Yu G, Liu B, Yu L. Curcumin promotes cholesterol efflux from brain through LXR/RXR-ABCA1-apoA1 pathway in chronic cerebral hypoperfusion aging-rats. Molecular Neurodegeneration 2012; 7(1): S7.
92. Mutsuga M, Chambers JK, Uchida K, et al. Binding of curcumin to senile plaques and cerebral amyloid angiopathy in the aged brain of various animals and to neurofibrillary tangles in Alzheimer's brain. J Vet Med Sci 2012; 74(1): 51-7.
93. Liu L, Zhang P, Li Y, Yu G. Curcumin protects brain from oxidative stress through inducing expression of UCP2 in chronic cerebral hypoperfusion aging-rats. Molecular Neurodegeneration 2012; 7(Suppl 1): S10.
94. Agrawala R MB, Tyagia E,Nathb C,Shukla R. Effect of curcumin on brain insulin receptors and memory functions in STZ (ICV) induced dementia model of rat. Pharmacological Research 2010; 61(3): 247-52.
95. Shukla PK KV, Ali MM, Khan MY, Srimal RC. Anti-ischemic Effect of Curcumin in Rat Brain. Neurochemical Research 2008; 33(6): 1036-43.
96. Huanga Z ZX, Lia Z, Fenga C, Pana A, Mao Q. Curcumin reverses corticosterone-induced depressive-like behavior and decrease in brain BDNF levels in rats. Neuroscience Letters 2011; 493(3): 145-8.
97. Pillai GR, Srivastava AS, Hassanein TI, Chauhan DP, Carrier E. Induction of apoptosis in human lung cancer cells by curcumin. Cancer Letters 2004; 208(2): 163-70.
98. Alexandrow MG, Song LJ, Altiok S, Gray J, Haura EB, Kumar NB. Curcumin: a novel Stat3 pathway inhibitor for chemoprevention of lung cancer. European Journal of Cancer Prevention 2011; In Press.
99. Deryugina EI, Quigley JP. The Role of Matrix Metalloproteinases in Cellular Invasion and Metastasis. Biology of Extracellular Matrix 2011; 2: 145-19.
100. Song-Shei, Lai KC, Shu-Chun Hsu, et al. Curcumin inhibits the migration and invasion of human A549 lung cancer cells through the inhibition of matrix metalloproteinase-2 and -9 and Vascular Endothelial Growth Factor (VEGF). Cancer Letters 2009; 285(2): 127-33.
101. Lee JC, Kinniry PA, Arguiri E, et al. Dietary Curcumin Increases Antioxidant Defenses in Lung, Ameliorates Radiation-Induced Pulmonary Fibrosis, and Improves Survival in Mice. Radiation Research 2010; 173(5): 590-601.
102. Lüer S, Troller R, Jetter M, Spaniol V, Aebi C. Topical curcumin can inhibit deleterious effects of upper respiratory tract bacteria on human oropharyngeal cells in vitro: potential role for patients with cancer therapy induced mucositis? Supportive Care in Cancer 2011; 19(6): 799-806.
103. Farhangkhoee H, Khan ZA, Mukherjee S, et al. Heme oxygenase in diabetes-induced oxidative stress in the heart. J Mol Cell Cardiol 2003; 35(12): 1439-48.
104. Brouet I, Ohshima H. Curcumin,an anti-tumour promoter and antiinflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. Biochem Biophys Res Commun 1995; 206(2): 533-40.
105. Farhangkhoee H, Khan ZA, Chen S, Chakrabarti S. Differential effects of curcumin on vasoactive factors in the diabetic rat heart. Nutr Metab (Lond) 2006; 3: 27.
106. Venkatesan N. Curcumin attenuation of acute adriamycin myocardial toxicity in rats. Br J Pharmacol 1998; 124(3): 425-7.
107. Daosukho C, Chen Y, Noel T, et al. Phenylbutyrate, a histone deacetylase inhibitor, protects against adriamycin-induced cardiac injury. Free Radic Biol Med 2007; 42(12): 1818-25.
108. Gusterson RJ, Jazrawi E, Adcock IM, Latchman DS. The transcriptional co-activators CREB-binding protein (CBP) and p300 play a critical role in cardiac hypertrophy that is dependent on their histone acetyltransferase activity. J Biol Chem 2003; 278(9): 6838-47.
109. Yanazume T, Hasegawa K, Morimoto T, et al. Cardiac p300 is involved in myocyte growth with decompensated heart failure. Mol Cell Biol 2003; 23(10): 3593-606.
110. Li HL, Liu C, Couto G, et al. Curcumin prevents and reverses murine cardiac hypertrophy. J Clin Invest 2008; 118(3): 879-93.
111. Morimoto T, Sunagawa Y, Kawamura T, et al. The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats. J Clin Invest 2008; 118(3): 868-7.
112. Marcu M.G., Jung Y, Lee S, et al. Curcumin is an inhibitor of p300 histone acetylatransferase. Med Chem 2006; 2(2): 169-74.
113. Virani SS, Polsani VR, Nambi V. Novel markers of inflammation in atherosclerosis. Curr Atheroscler Rep 2008; 10(2): 164-70.
114. Schoonderwoerd BA, Smit MD, Pen L, Van Gelder IC. New risk factors for atrial fibrillation: causes of 'not-so-lone atrial fibrillation'. Europace 2008; 10(6): 668-73.
115. Goel A, Kunnumakkara AB, Aggarwal BB. Curcumin as "Curecumin": from kitchen to clinic. Biochem Pharmacol 2008; 75(4): 787-809.
116. Shishodia S, T S. Chaturvedi MM. Modulation of transcription factors by curcumin. Adv Exp Med Biol 2007; 595: 127-48.
117. Pae HO, Jeong GS, Jeong SO, et al. Roles of heme oxygenase-1 in curcumin-induced growth inhibition in rat smooth muscle cells. Exp Mol Med 2007; 39(3): 267-77.
118. Durante W. Heme oxygenase-1 in growth control and its clinical application to vascular disease. J Cell Physiol 2003; 195(3): 373-82.
119. Li Y, Chen ZQ, Li YD. Effects of curcumin on the epithelial mesenchymal transition and TGF-beta/Smads signaling pathway in unilateral ureteral obstruction rats. Zhongguo Zhong Xi Yi Jie He Za Zhi 2011; 31(9): 1224-8.
120. Ahmed MH, Ashton N, Balment RJ. Renal function in a rate model of analgesic nephropathy: Effect of chloroquine. J Pharmacol Exp Ther 2003; 305(1): 123-30.
121. Yousef MI, Omar SAM, El-Guendi MI, Abdelmegid LA. Potential protective effects of quercetin and curcumin on paracetamolinduced histological changes, oxidative stress, impaired liver and kidney functions and haematotoxicity in rat. Food and Chemical Toxicol 2010; 48(11): 3246-61.
122. Shahed AR, Jones E, Shoskes D. Quercetin and curcumin upregulate antioxidant gene expression in rat kidney after ureteral obstruction or ischemia/reperfusion injury. Transplantation Proceedings 2001; 33(6): 2988.
123. El-Nahas AF, El-Ashmawy IM. Reproductive and cytogenetic toxicity of metronidazole in male mice. Basic Clin Pharmacol Toxicol 2004; 94(5): 226-33.
124. Noorafshan A, KarbalayDoust S, Valizadeh A, Aliabadi E. Ameliorative effects of curcumin on the structural parameters of seminiferous tubules and Leydig cells in metronidazole-treated mice: A stereological approach. Exp Toxicologic Pathol 2011; 63: 627-33.
125. Farombi EO, Abarikwu SO, Adedara IA, Oyeyemi MO. Curcumin and Kolaviron Ameliorate Di-n-Butylphthalate-Induced Testicular Damage in Rats. Basic & Clinical Pharmacology Toxicol 2007; 100(1): 43-8.
126. Tsutsumi T, Ichihara T, Kawabe M, et al. Renal toxicity induced by folic acid is associated with the enhancement of male reproductive toxicity of di (n-butyl)phthalate in rats. Reprod Toxicol 2004; 18(1): 35-42.
127. Mathuria N, Verma RJ. Curcumin ameliorates aflatoxin-induced toxicity in mice spermatozoa. Fertil Steril 2008; 90(3): 775-80.
128. Giannessi F, Giambelluca MA, Grasso L, Scavuzzo MC, Ruffoli R. Curcumin protects Leydig cells of mice from damage induced by chronic alcohol administration. Med Sci Monit 2008; 14(11): 237-42.
129. Giannessi F, Giambelluca MA, Grasso L, Scavuzzo MC, Ruffoli R. Curcumin protects Leydig cells of mice from damage induced by chronic alcohol administration. Med Sci Monit 2008; 14(11): 237-42.
130. Ilbey YO, Ozbek E, Cekmen M, Simsek A, Otunctemur A, Somay A. Protective effect of curcumin in cisplatin-induced oxidative injury in rat testis: mitogen-activated protein kinase and nuclear factor-kappa B signaling pathways. Hum Reprod 2009; 24(7): 1717-25.
131. Hong JH, Ahn KS, Bae E, Jeon SS, Choi HY. The effects of curcumin on the invasiveness of prostate cancer in vitro and in vivo. Prostate Cancer and Prostatic Diseases 2006; 9: 147-52.
132. Chendil D, Ranga RS, Meigooni D, Sathishkumar S, Ahmed MM. Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3. Oncogene 2004; 23: 1599-607.
133. Nonn L, Duong D, Peehl DM. Chemopreventive anti-inflammatory activities of curcumin and other phytochemicals mediated by MAP kinase phosphatase-5 in prostate cells Carcinogenesis 2007; 28(6): 1188-96.
134. Ohtsu H, Xiao Z, Ishida J, et al. Antitumor Agents. 217. Curcumin Analogues as Novel Androgen Receptor Antagonists with Potential as Anti-Prostate Cancer Agents. J Med Chem 2002; 45(23): 5037-42.
135. Jones RE, López KH. Human Reproductive Biology. Oxford: Academic Press; 2006.
136. Madhavi K, Kumar R. In vivo Toxicological Evaluation Of Organophosphate Pesticide On Female Albino Mice: Therapeutic Effects Of Curcumin. Int J Pharm Sci Res 2010; 1(9): 86-92.
137. El-Sayed ESM. The Uterine Relaxant Effect Of Curcumin In Rats; An In vitro Study. J Basic Applied Sci 2008; 4(1): 45-8.
138. Itthipanichpong C, Ruangrungsi N, Kemsri W, Sawasdipanich A. Antispasmodic effects of curcuminoids on isolated guinea-pig ileum and rat uterus. J Med Assoc Thai 2003; 86(2): 299-309.
139. Liduan Z, Qiangsong T, Cuihuan W. Growth-inhibitory effects of curcumin on ovary cancer cells and its mechanisms. Journal of Huazhong University of Science and Technology 2004; 24(1): 55-8.
140. Shi M, Cai Q, Yao L, Mao Y, Ming Y, Ouyang G. Antiproliferation and apoptosis induced by curcumin in human ovarian cancercells. Cell Biology International 2006; 30(3): 221-6.
141. Singh M, Singh N. Curcumin counteracts the proliferative effect of estradiol and induces apoptosis in cervical cancer cells. Molecular and Cellular Biochemistry 2011; 347(1-2).
142. Thapa BR, Walia A. Liver function tests and their interpretation. Indian J Pediatr 2007; 74 (7): 663-71.
143. Yousef MI, El-Demerdash FM, Radwan FME. Sodium arseniteinduced biochemical perturbations in rats: Ameliorating effect of curcumin. Food Chem Toxicol 2008; 46(11): 3506-11.
144. Messner DJ, Sivam G, Kowdley KV. Curcumin reduces the toxic effects of iron loading in rat liver epithelial cells. Liver International 2008; 29(1): 63-72.
145. Schrader C, Schiborr C, Frank J, Rimbach G. Curcumin induces paraoxonase 1 in cultured hepatocytes in vitro but not in mouse liver in vivo. British Journal of Nutrition 2011; 28(105): 167-70
146. Seehofer D, Schirmeier A, Bengmark S, et al. Inhibitory Effect of Curcumin on Early Liver Regeneration Following Partial Hepatectomy in Rats. Journal of Surgical Research 2009; 155(2): 195-200.
147. Farombi EO, Shrotriya S, Na HK, Kim SH, Surh YJ. Curcumin attenuates dimethylnitrosamine-induced liver injury in rats through Nrf2-mediated induction of heme oxygenase-1. Food and Chemical Toxicology 2008; 46(4): 1279-87.
148. Fu Y, Zheng S, Lin J, Ryerse J, Chen A. Curcumin Protects the Rat Liver from CCl4-Caused Injury and Fibrogenesis by Attenuating Oxidative Stress and Suppressing Inflammation Molecular Pharmacology 2008; 73(2): 399-409
149. Wang L, Shen Y, Song R, Sun Y, Xu J, Xu Q. An Anticancer Effect of Curcumin Mediated by Down-Regulating Phosphatase of Regenerating Liver-3 Expression on Highly Metastatic Melanoma Cells Molecular Pharmacology 2009 76 (6): 1238-45
150. Bruck R, Ashkenazi M, Weiss S, et al. Prevention of liver cirrhosis in rats by curcumin. Liver International 2007; 27(3): 373-83.
151. Irving GR, Karmokar A, Berry DP, Brown K, Steward WP. Curcumin: the potential for efficacy in gastrointestinal diseases. Best Pract Res Clin Gastroenterol 2011; 25(4-5): 519-34.
152. Ali T, Shakir F, Morton J. Curcumin and Inflammatory Bowel Disease: Biological Mechanisms and Clinical Implication. Digestion 2012 85(4): 249-55.
153. Taylor RA, Leonard MC. Curcumin for inflammatory bowel disease: a review of human studies. Altern Med Rev 2011; 16(2): 152-6.
154. Maheshwari R, Singh AK, Gaddipati J, Srimal RC. Multiple biological activities of curcumin: A short review. Life Sci 2006; 78(18): 2081-7.
155. S. Darvesh A, B. Aggarwal B, Bishayee A. Curcumin and Liver Cancer: A Review. Curr Pharm Biotechnol 2012; 13(1): 218-28(11).
156. Onodera S, Kaneda K, Mizue Y, Koyama Y, Fujinaga M, Nishihira J. Macrophage migration inhibitory factor up-regulates expression of matrix metalloproteinases in synovial fibroblasts of rheumatoid arthritis. J Biol Chem 2000; 275(1): 444-50.
157. Lev-Ari S, Strier L, Kazanov D, et al. Curcumin synergistically potentiates the growth-inhibitory and pro-apoptotic effects of celecoxib in osteoarthritis synovial adherent cells. Rheumatology (Oxford) 2006; 45(2): 171-7.
158. Avci G, Kadioglu H, Sehirli AO, et al. Curcumin Protects Against Ischemia/Reperfusion Injury in Rat Skeletal Muscle. Journal of Surgical Research 2012; 172(1): e39-e46.
159. Vazeille E, Slimani L, Claustre A, et al. Curcumin treatment prevents increased proteasome and apoptosome activities in rat skeletal muscle during reloading and improves subsequent recovery The Journal of Nutritional Biochemistry 2012; 23(3): 245-51.
160. Poylin V, Fareed MU, O'Neal P, et al. The NF-kappaB Inhibitor Curcumin Blocks Sepsis-Induced Muscle Proteolysis. Mediators Inflamm 2008; 2008: 317851.
161. Na LX, Zhang YL, Li Y, et al. Curcumin improves insulin resistance in skeletal muscle of rats. Nutrition, Metabolism and Cardiovascular Diseases 2011; 21(7): 526-33.
162. Davis JM, Murphy EA, Carmichael MD, et al. Curcumin effects on inflammation and performance recovery following eccentric exercise-induced muscle damage. AJP - Regu Physiol 2007; 292(6): R2168-R73.
163. Davis M. Effects of Curcumin and Quercetin on Inflammation and Fatigue with Muscle Damage, Cancer and Infection. Med Sci Sports Exercise 2009; 41 (5): 53.
164. Maheshwari RK, Singh AK, Gaddipati J, Srimal RC. Multiple biological activities of curcumin: a short review. Life Sci 2006; 78(18): 2081-7.
165. Kurd SK, Smith N, VanVoorhees A, et al. Oral curcumin in the treatment of moderate to severe psoriasis vulgaris: a prospective clinical trial. J Am Acad Dermatol 2008; 58(4): 625-31.
166. Ashkani-Esfahani S, Imanieh MH, Khoshneviszadeh M, et al. The Healing Effect of Arnebia Euchroma in Second Degree Burn Wounds in Rat as an Animal Model. Iran Red Crescent Med J 2012; 14(2): 70-4.
167. Ashkani-Esfahani S, Emami Y, Esmaeilzadeh E, Bagheri F, Namazi MR. Glucosamine Enhances Tissue Regeneration in the Process of Wound Healing in Rats as Animal Model: A Stereological Study. J Cytol Histol 2012; 3: 150.
168. γ radiation. Int Wound J 2012 9(1): 76-92.
169. López-Jornet P, Camacho-Alonso F, Jiménez-Torres MJ, Orduña- Domingo A, Gómez-García F. Topical curcumin for the healing of carbon dioxide laser skin wounds in mice. Photomed Laser Surg 2011; 29(12): 809-14.
170. Pari L, Murugan P. Antihyperlipidemic effect of curcumin and tetrahydrocurcumin in experimental type 2 diabetic rats. Ren Fail 2007; 29(7): 881-9.
171. Pari L, Murugan P. Tetrahydrocurcumin prevents brain lipid peroxidation in streptozotocin-induced diabetic rats. J Med Food 2007; 10(2): 323-9.
172. Mahesh T, Sri-Balasubashini MM, Menon VP. Photo-irradiated curcumin supplementation in streptozotocin-induced diabetic rats: effect on lipid peroxidation. Therapie 2004; 59(6): 639-44.
173. Nishiyama T, Mae T, Kishida H, et al. Curcuminoids and sesquiterpenoids in turmeric (Curcuma longa L.) suppress an increase in blood glucose level in type 2 diabetic KK-Aymice. J Agric Food Chem 2005; 53(4): 959-63.
174. Suryanarayana P, Satyanarayana A, Balakrishna N, Kumar PU, Reddy GB. Effect of turmeric and curcumin on oxidative stress and antioxidant enzymes in streptozotocin-induced diabetic rat. Med Sci Monit 2007; 13(12): BR286-92.
175. Sharma S, Kulkarni SK, Chopra K. Curcumin, the active principle of turmeric (Curcuma longa), ameliorates diabetic nephropathy in rats. Clin Exp Pharmacol Physiol 2006 b; 33(10): 940-5.
176. Farhangkhoee H, Khan ZA, Chen S, Chakrabarti S. Differential effects of curcumin on vasoactive factors in the diabetic rat heart. Nutr Metab (Lond) 2006; 3: 27.
177. Feng B, Chen S, Chiu J, George B, Chakrabarti S. Regulation of cardiomyocyte hypertrophy in diabetes at the transcriptional level. Am J Physiol Endocrinol Metab 2008.; 294(6): E1119-E26.
178. Aggarwal BB, Bhatt ID, Ichikawa H, et al. Curcumin - biological and medicinal properties. In: Ravindran PN, Babu KN, Sivaraman K, editors. Turmeric the Genus Curcuma. NY: CRC Press; 2007. p. 297-368.
179. Shao ZM, Shen ZZ, Liu CH, et al. Curcumin exerts multiple suppressive effects on human breast carcinoma cells. Int J Cancer 2002; 98(2): 234-40.
180. Schindler R, Mentlein R. Flavonoids and vitamin E reduce the release of the angiogenic peptide vascular endothelial growth factor from human tumor cells. J Nutr 2006; 136(6): 1477-82.
181. Ramachandran C, Fonseca HB, Jhabvala P, Escalon EA, Melnick SJ. Curcumin inhibits telomerase activity through human telomerase reverse transcriptase in MCF-7 breast cancer cell line. Cancer Lett 2002; 184(1): 1-6.
182. Di GH, Li HC, Shen ZZ, Shao ZM. Analysis of antiproliferation of curcumin on human breast cancer cells and its mechanism. Zhonghua Yi Xue Za Zhi 2003; 83(20): 1764-8.
183. Yoon H, Liu RH. Effect of selected phytochemicals and apple extracts on NF-kappaB activation in human breast cancer MCF-7 cells. J Agric Food Chem 2007; 55(8): 3167-73.
184. Xia X, Cheng G, Pan Y, Xia ZH, Kong LD. Behavioral, neurochemical, neuroendocrine effects of the ethanolic extract from Curcuma longa L.in the mouse forced swimming test. J Ethnopharmacol 2007; 110(2): 356-63.
185. Poma P, Notarbartolo M, Labbozzetta M, et al. The antitumor activities of curcumin and of its isoxazole analogue are not affected by multiple gene expression changes in an MDR model of the MCF-7 breast cancer cell line: analysis of the possible molecular basis. Int J Mol Med 2007; 20(3): 329-35.
186. Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, Aggarwal BB. Curcumin and cancer: an old-age disease with an age-old solution. Cancer Letters 2008; 267(1): 133-64.
187. Rafiee P, Ogawa H, Heidemann J, et al. Isolation and characterization of human esophageal microvascular endothelial cells: mechanisms of inflammatory activation. Am J Physiol Gastrointest Liver Physiol 2003; 285: G1277-G92.
188. Wax A, Pyhtila JW, Graf RN, et al. Prospective grading of neoplastic change in rat esophagus epithelium using angle-resolved low-coherence interferometry. J Biomed Opt 2005; 10(5): 051604.
189. Wei SC, Lin YS, Tsao PN, Wu-Tsai JJ, Wu CH, Wong JM. Comparison of the anti-proliferation and apoptosis-induction activities of sulindac, celecoxib, curcumin, and nifedipine in mismatch repair-deficient cell lines. J Formos Med Assoc 2004; 103(8): 599-606.
190. Scott DW, Loo G. Curcumin-induced GADD153 gene upregulation in human colon cancer cells. Carcinogenesis 2004; 25(11): 2155-64.
191. Rashmi R, Kumar S, Karunagaran D. Human colon cancer cells lacking Bax resist curcumin-induced apoptosis and Bax requirement is dispensable with ectopic expression of Smac or downregulation of Bcl-xL. Carcinogenesis 2005; 26(4): 713-23.
192. Du B, Jiang L, Xia Q, Zhong L. Synergistic inhibitory effects of curcumin and 5-fluorouracil on the growth of the human colon cancer cell line HT-29. Chemotherapy 2006; 52(1): 23-8.
193. Moussavi M, Assi K, Gomez-Munoz A, Salh B. Curcumin mediates ceramide generation via the de novo pathway in colon cancer cells. Carcinogenesis 2006; 27(8): 1636-44.
194. Wijnands MV, Erk MJv, Doornbos RP, Krul CA, Woutersen RA. Do aberrant crypt foci have predictive value for the occurrence of colorectal tumours? Potential of gene expression profiling in tumours. Food Chem Toxicol 2004; 42(10): 1629-39.
195. Volate SR, Davenport DM, Muga SJ, Wargovich MJ. Modulation of aberrant crypt foci and apoptosis by dietary herbal supplements (quercetin, curcumin, silymarin, ginseng and rutin). Carcinogenesis 2005; 26(8): 1450-6.
196. Li L, Ahmed B, Mehta K, Kurzrock R. Liposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis, and angiogenesis in colorectal cancer. Mol Cancer Ther 2007; 6(4): 1276-82.
197. Vietri M, Pietrabissa A, Mosca F, Spisni R, Pacifici GM. Curcumin is a potent inhibitor of phenol sulfotransferase (SULT1A1) in human liver and extrahepatic tissues. Xenobiotica 2003; 33(4): 357-63.
198. Chen YN, Cheng CC, Chen JC, Tsauer W, Hsu SL. Norcantharidin-induced apoptosis is via the extracellular signalregulated kinase and c-Jun-NH2-terminal kinase signaling pathways in human hepatoma HepG2 cells. Br J Pharmacol 2003; 140(3): 461-70.
199. Bae MK, Kim SH, Jeong JW, et al. Curcumin inhibits hypoxiainduced angiogenesis via down-regulation of HIF-1. Oncol Rep 2006; 15(6): 1557-62.
200. Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 2003; 23(1A): 363-98.
201. Wang W, Abbruzzese JL, Evans DB, Larry L, Cleary KR, Chiao PJ. The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. Clin Cancer Res 1999; 5(1): 119-27.
202. Khanbolooki S, Nawrocki ST, Arumugam T, Andtbacka R, Pino MS, Kurzrock R, et al. Nuclear factor-kappaB maintains TRAIL resistance in human pancreatic cancer cells. Mol Cancer Ther 2006; 5: 2251-60.
203. Jutooru I, Chadalapaka G, Lei P, Safe S. Inhibition of NFκB and Pancreatic Cancer Cell and Tumor Growth by Curcumin Is Dependent on Specificity Protein Down-regulation. J Biological Chem 2010; 285(33): 25332-44.
204. Lev-Ari S, Starr A, Vexler A, et al. Inhibition of pancreatic and lung adenocarcinoma cell survival by curcumin is associated with increased apoptosis, downregulation of COX-2 and EGFR and inhibition of Erk1/2 activity. Anticancer Res 2006; 26(6B): 4423-30.
205. Wang Z, Zhang Y, Banerjee S, Li Y, Sarkar FH. Notch-1 downregulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells. Cancer Lett 2006; 106(11): 2503-13.
206. Lev-Ari S, Vexler A, Starr A, et al. Curcumin augments gemcitabine cytotoxic effect on pancreatic adenocarcinoma cell lines. Cancer Invest 2007; 25(6): 411-8.
207. Dhillon N, Aggarwal BB, Newman RA, et al. Curcumin and pancreatic cancer: phase II clinical trial experience. J Clin Oncol 2007; 25: 4599.
208. Kamat AM, Sethi G, Aggarwal BB. Curcumin potentiates the apoptotic effects of chemotherapeutic agents and cytokines through down-regulation of nuclear factor-kappaB and nuclear factorkappaB- regulated gene products in IFN-alpha-sensitive and IFNalpha- resistant human bladder cancer cells. Mol Cancer Ther 2007; 6(3): 1022-30.
209. Tharakan ST, Inamoto T, Sung B, Aggarwal BB, Kamat AM. Curcuminpotentiates the antitumor effects of gemcitabine in an orthotopic model of human bladder cancer through suppression of proliferative and angiogenic biomarkers. Biochemical Pharmacology 2010; 79(2): 218-28.
210. Jung EM, Lim JH, Lee TJ, Park JW, Choi KS, Kwon TK. Curcumin sensitizes tumor necrosis factor-related apoptosisinducing ligand (TRAIL)-induced apoptosis through reactive oxygen species-mediated upregulation of death receptor 5 (DR5). Carcinogenesis 2005; 26: 1905-13.
211. Iqbal M, Okazaki Y, Okada S. In vitro curcumin modulates ferric nitrilotriacetate (Fe-NTA) and hydrogen peroxide (H2O2)-induced peroxidation of microsomal membrane lipids and DNA damage. Teratog Carcinog Mutagen 2003; 23(S1): 151-60.
212. Woo JH, Kim YH, Choi YJ, et al. Molecular mechanisms of curcumin induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt. Carcinogenesis 2003; 24(7): 1199-208.
213. Frank N, Knauft J, Amelung F, Nair J, Wesch H, Bartsch H. No prevention of liver and kidney tumors in Long-Evans Cinnamon rats by dietary curcumin, but inhibition at other sites and of metastases. Mutat Res 2003; 523-524: 127-35.
214. Khor TO, Keum YS, Lin W, et al. Combined inhibitory effects of curcumin and phenethyl isothiocyanate on the growth of human PC-3 prostate xenografts in immunodeficient mice. Cancer Res 2006; 66: 613-21.
215. Hong JH, Ahn KS, Bae E, Jeon SS, Choi HY. The effects of curcumin on the invasiveness of prostate cancer in vitro and in vivo. Prostate Cancer Prostatic Dis 2006; 9: 147-52.
216. Purkayastha S, Berliner A, Fernando SS, et al. Curcumin blocks brain tumor formation. Brain Research 2009; 1266: 130-8.
217. Karmakar S, Banik NL, Ray SK. Curcumin suppressed antiapoptotic signals and activated cysteine proteases for apoptosis in human malignant glioblastoma U87MG cells. Neurochem Res 2007; 32(12): 2103-13.
218. Dhandapani KM, Mahesh VB, Brann DW. Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NFκB transcription factors. J Neurochem Res 2007; 102(2): 522-38.
219. Kim SY, Jung SH, Kim HS. Curcumin is a potent broad spectrum inhibitor of matrix metalloproteinase gene expression in human astroglioma cells. Biochem Biophys Res Commun 2005; 337: 510-6.
220. Kang SK, Cha SH, Jeon HG. Curcumin-induced histone hypoacetylation enhances caspase-3-dependent glioma cell death and neurogenesis of neural progenitor cells. Stem Cells Dev 2006; 15(2): 165-74.
221. Gao X, Deeb D, Jiang H, Liu YB, Dulchavsky SA, Gautam SC. Curcumin differentially sensitizes malignant glioma cells to TRAIL/Apo2L-mediated apoptosis through activation of procaspases and release of cytochrome c from mitochondria. J Exp Ther Oncol 2005; 5: 39-48.
222. Shinojima N, Yokoyama T, Kondo Y, Kondo S. Roles of the Akt/mTOR/p70S6K and ERK1/2 signaling pathways in curcumininduced autophagy. Autophagy 2007; 3(6): 635-7.
223. Aoki H, Takada Y, Kondo S, Sawaya R, Aggarwal BB, Kondo Y. Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways. Mol Pharmacol 2007; 72(1): 29-39.
224. Chen YS, Ho CC, Cheng KC, et al. Curcumin inhibited the arylamines N-acetyltransferase activity, gene expression and DNA adduct formation in human lung cancer cells (A549). Toxicol In vitro 2003; 17(3): 323-33.
225. Wu SH, Hang LW, Yang JS, et al. Curcumin Induces Apoptosis in Human Non-small Cell Lung Cancer NCI-H460 Cells through ER Stress and Caspase Cascade- and Mitochondria-dependent Pathways. Anticancer Res 2010; 30(6): 2125-33
226. Alexandrow MG, Song LJ, Altiok S, Gray J, Haura EB, Kumar NB. Curcumin: a novel Stat3 pathway inhibitor for chemoprevention of lung cancer. European Journal of Cancer Prevention 2011; Publish Ahead of Print: 10.1097/CEJ.0b013e32834ef194.
227. Anto RJ, Maliekal TT, Karunagaran D. L-929 cells harboring ectopically expressed RelA resist curcumininduced apoptosis. J Biol Chem 2000; 275: 15601-4.
228. Kondo A, Mogi M, Koshihara Y, Togari A. Signal transduction system for interleukin-6 and interleukin-11 synthesis stimulated by epinephrine in human osteoblasts and human osteogenic sarcoma cells. Biochem Pharmacol 2001; 61(3): 319-26.
229. Ravindran J, Prasad S, Aggarwal BB. Curcumin and Cancer Cells: How Many Ways Can Curry Kill Tumor Cells Selectively?. The AAPS J 2009; 11(3): 495-510.
230. Walters DK, Muff R, Langsam B, Born W, Fuchs B. Cytotoxic effects of curcumin on osteosarcoma cell lines. Invest New Drugs 2008; 26(4): 289-97.